Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v12-FR | Version v9-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2023-09-06 | 2023-08-09 |
| Drug Identification Number | 02302438 | 02302438 |
| Brand name | XYLOCAINE 2% | XYLOCAINE 2% |
| Common or Proper name | lidocaine HCI 2% Plain 10x50mL MD Vial | lidocaine HCI 2% Plain 10x50mL MD Vial |
| Company Name | ASPEN PHARMACARE CANADA INC. | ASPEN PHARMACARE CANADA INC. |
| Ingredients | LIDOCAINE HYDROCHLORIDE | LIDOCAINE HYDROCHLORIDE |
| Strength(s) | 20MG | 20MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | BLOCK/INFILTRATION BLOCK/INFILTRATION | BLOCK/INFILTRATION BLOCK/INFILTRATION |
| Packaging size | 10 vials | 10 vials |
| ATC code | N01BB | N01BB |
| ATC description | ANESTHETICS, LOCAL | ANESTHETICS, LOCAL |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | 2023-08-20 | 2023-08-20 |
| Actual start date | ||
| Estimated end date | 2023-08-20 | 2023-08-20 |
| Actual end date | 2023-08-17 | |
| Shortage status | Avoided shortage | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | VR44565CA1 XYLOCAINE 20MG/ML LIQ MDV 10X50ML CA ASP | VR44565CA1 XYLOCAINE 20MG/ML LIQ MDV 10X50ML CA ASP |
| Health Canada comments |